
Dringend
Gesundheit·01.06.2026KI-Zusammenfassung
CEPI Pledges $60 Million to Accelerate Development of Bundibugyo Ebolavirus Vaccines
CEPI is urgently accelerating the development of three vaccine candidates against Bundibugyo ebolavirus (BDBV), pledging over $60 million to combat the raging outbreak in the Democratic Republic of the Congo. No licensed vaccines currently exist for this strain.
A
Ars Technica